ECCOGENE INC. is a clinical-stage biopharmaceutical company developing best-in-class small molecule therapeutics for chronic cardiometabolic and inflammatory conditions. It raised CNY 180 million in Series B financing to advance its metabolic disease pipeline. The company is based in Cambridge, MA, with a registered address in Albany, NY.
Filed April 29, 2025 · Albany, NY
Your competitors in Albany are getting unlimited new business leads.
ECCOGENE INC. is a biopharmaceuticals business (Corp) registered on April 29, 2025 with the New York Division of Corporations. The business is located in Albany, New York.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
ECCOGENE INC. was registered as Corp on April 29, 2025 in New York.
ECCOGENE INC.'s principal address on file is Albany, NY, 12207.
ECCOGENE INC. is classified as a biopharmaceuticals business (small molecule therapeutics for metabolic diseases).
No EIN was found on file for ECCOGENE INC. at the time of registration.
Based on the business category, these service providers typically target this type of business.